TY - JOUR
T1 - Choroidal thickness in nonarteritic anterior ischaemic optic neuropathy
T2 - A study with optical coherence tomography
AU - Dias-Santos, Arnaldo
AU - Ferreira, Joana
AU - Abegão Pinto, Luís
AU - Vicente, André
AU - Anjos, Rita
AU - Cabugueira, Ana
AU - Flores, Rita
AU - Cunha, João Paulo
PY - 2014/8
Y1 - 2014/8
N2 - Nonarteritic anterior ischemic optic neuropathy (NA-AION) is the most common nonglaucomatous optic neuropathy in adults over 50 years of age. It is usually related to cardiovascular risk factors. The primary objective of this study was to evaluate choroidal thickness in patients with chronic NA-AION, and the secondary objective was to evaluate macular thickness in these patients. This cross-sectional study compared two groups: group 1 included 20 eyes of 20 patients with chronic NA-AION, and group 2 included 31 eyes of 31 healthy controls. In both groups, the choroidal thickness was measured using the enhanced depth imaging program of Heidelberg Spectralis® optical coherence tomography (Heidelberg Engineering, Heidelberg, Germany). The macular thickness was also measured using the automatic software of the same device. The mean follow-up time after NA-AION in group 1 was 57.17±26.92 months. The mean choroidal thickness of the posterior pole was 244.38±61.03m in group 1 and 214.18±65.97m in group 2 (p=0.004). The mean macular thickness was higher in group 2. Macular thickness is reduced in eyes that had an episode of NA-AION, whereas choroidal thickness is generally higher in these eyes when compared with normal eyes. The increase in choroidal thickness may be due to a local dysfunction in vascular autoregulatory mechanisms, which may predispose to ischemic phenomena.
AB - Nonarteritic anterior ischemic optic neuropathy (NA-AION) is the most common nonglaucomatous optic neuropathy in adults over 50 years of age. It is usually related to cardiovascular risk factors. The primary objective of this study was to evaluate choroidal thickness in patients with chronic NA-AION, and the secondary objective was to evaluate macular thickness in these patients. This cross-sectional study compared two groups: group 1 included 20 eyes of 20 patients with chronic NA-AION, and group 2 included 31 eyes of 31 healthy controls. In both groups, the choroidal thickness was measured using the enhanced depth imaging program of Heidelberg Spectralis® optical coherence tomography (Heidelberg Engineering, Heidelberg, Germany). The macular thickness was also measured using the automatic software of the same device. The mean follow-up time after NA-AION in group 1 was 57.17±26.92 months. The mean choroidal thickness of the posterior pole was 244.38±61.03m in group 1 and 214.18±65.97m in group 2 (p=0.004). The mean macular thickness was higher in group 2. Macular thickness is reduced in eyes that had an episode of NA-AION, whereas choroidal thickness is generally higher in these eyes when compared with normal eyes. The increase in choroidal thickness may be due to a local dysfunction in vascular autoregulatory mechanisms, which may predispose to ischemic phenomena.
KW - Choroidal thickness
KW - Enhanced depth imaging
KW - Macular thickness
KW - Nonarteritic anterior ischemic optic neuropathy
KW - Optical coherence tomography
UR - http://www.scopus.com/inward/record.url?scp=84904606402&partnerID=8YFLogxK
U2 - 10.3109/01658107.2014.926943
DO - 10.3109/01658107.2014.926943
M3 - Article
AN - SCOPUS:84904606402
SN - 0165-8107
VL - 38
SP - 173
EP - 179
JO - Neuro-Ophthalmology
JF - Neuro-Ophthalmology
IS - 4
ER -